Search - tctmd.com

Displaying 881 - 900 of 1027

Sort: Relevancy | Date

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Daily News

Balloon Occlusion Bests Filter in Cerebral Protection After Carotid Stenting

Yael L. Maxwell

November 28, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

November 22, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

November 21, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

November 17, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

November 10, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

November 10, 2011

News Conference News

RIFLE STEACS: Radial Approach Safer Than Femoral in STEMI

November 09, 2011

News Industry News

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

November 09, 2011

News Industry News

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

November 09, 2011

Advertisement

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Balloon Occlusion Bests Filter in Cerebral Protection After Carotid Stenting

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Two New SES Show Improvement Over First-Generation Stents

Rotablation does not improve efficacy of drug-eluting stents in complex calcified coronary lesions

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

RIFLE STEACS: Radial Approach Safer Than Femoral in STEMI

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content